About Sandoz
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Basel, BS
- Company type
- Public Company
Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc
Specialties
- Generics
- Biosimilars
- and Over the counter medicines
Company locations
Centralbahnstrasse 4, Basel, BS 4051, CH
Industriestrasse 25, Holzkirchen, Bavaria 83607, DE
100 College Rd W, Princeton, New Jersey 08540, US
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
Business areas
- Biopharma
- Medical
- Manufacturing
- Pharmaceutical
- Biotech & Pharmaceuticals
- Pharmaceutical and biotechnology
On LinkedIn
- Followers
- 1,180,531
- People linked to this company
- 17,696
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
3,614,725,714 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.